KBP starts human clinical studies for seasonal flu vaccine
Kentucky Bioprocessing, an Owensboro-based biotech company, is beginning human clinical studies for its Quadrivalent Influenza Vaccine (QIV) to prevent seasonal flu. The clinical s…
Kentucky Bioprocessing, an Owensboro-based biotech company, is beginning human clinical studies for its Quadrivalent Influenza Vaccine (QIV) to prevent seasonal flu. The clinical s…